comparemela.com
Home
Live Updates
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2023 Earnings Call Transcript : comparemela.com
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2023 Earnings Call Transcript
Teva Pharmaceutical Industries Limited beats earnings expectations. Reported EPS is $1, expectations were $0.75.
Related Keywords
United States
,
Ireland
,
Canada
,
America
,
Canadian
,
American
,
Richard Francis
,
Glen Santangelo
,
Eric Hughes
,
Teva Pharmaceutical Industries Ltd
,
Teva Pharmaceutical Industries Limited
,
Teva Pharmaceutical Industries
,
Call Transcript January
,
Pharmaceutical Industries Limited
,
Pharmaceutical Industries
,
Eran Meir
,
Chief Medical Officer
,
Eli Kalif
,
North American
,
Healthy Future
,
Healthy People
,
Healthy Planet
,
Healthy Business
,
North America
,
Quality Supplement Brands In The
,
Canadian Dividend Stocks For Income
,
Yash Verma
,
comparemela.com © 2020. All Rights Reserved.